PRE 14C

PRE 14C Filing

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: August 11, 2020
Period of Report: August 11, 2020
Accession Number: 0001493152-20-015228

View Document ↗ View on SEC.gov ↗